Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3546

Actual shortage: 240 (7%)
Anticipated shortage: 3 (0%)
Avoided shortage: 11 (0%)
Resolved: 3292 (93%)

Discontinuation Reports

366

To be discontinued: 24 (7%)
Discontinued: 342 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

32 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DILTIAZ SR 90MG CAPSULE (SUSTAINED-RELEASE) Actual shortage 2017-08-13 2017-10-05 19030
APO-DILTIAZ SR 120MG CAPSULE (SUSTAINED-RELEASE) Actual shortage 2017-08-13 2017-10-05 19033
APO-DILTIAZ SR 60MG CAPSULE (SUSTAINED-RELEASE) Actual shortage 2017-08-13 2017-10-05 19027
APO-DIPIVEFRIN 0.1% LIQUID Actual shortage 2017-08-16 2017-10-05 19598
APO-DIPYRIDAMOLE Resolved 2018-08-21 2018-09-17 58589
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2017-06-06 2017-07-17 12059
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2017-06-15 2017-07-26 12805
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2018-01-03 2018-02-12 34844
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2018-01-03 2018-03-06 34847
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2018-04-16 2018-05-14 46024
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2019-01-08 2019-02-14 71475
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2019-02-13 2019-02-21 75617
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2019-06-26 2019-08-19 87512
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2019-07-03 2019-08-19 88331
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2019-09-04 2019-10-28 92968
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2019-09-04 2019-11-11 92971
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2020-05-13 2020-05-15 114944
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2020-09-09 2020-10-26 123921
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2020-09-17 2020-09-25 124347
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2021-01-08 2021-01-12 131154

Showing 1041 to 1060 of 3546

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-FENTANYL MATRIX 25MCG PATCH Discontinued 2018-09-07 2018-09-15 60489
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FLUVOXAMINE 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-FLUVOXAMINE 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110956
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959

Showing 161 to 180 of 366